This is a landmark study in so far as being the first to raise the alarm that, despite early successes with COVID-19 vaccines, further research is warranted on a next generation of COVID-19 vaccines. The results from this study, however, only indicate that the AstraZeneca vaccine does not have at least 60% efficacy against mild-moderate